Auxilium GmbH was founded in Essen in 2009. As the parent company, it serves as the interface for its subsidiaries, which provide services in the fields of home care, rehabilitation, orthopedics and footwear technology, and medical technology. The company now employs approximately 1,700 people across its subsidiaries and operates over 80 branches. Auxilium is considered the number one medical supply group in Germany.
Auxilium is backed by the Dutch investment holding company HAL: The parent company of Auxilium GmbH is HAL Investments, based in Rotterdam. HAL Investments is itself a subsidiary of the publicly traded HAL Holding N.V. (HAL Trust, Curaçao/Netherlands Antilles).
Since 2022, rahm has been led by the co-CEOs Meike Rahm and Marco Hammerstein; it recently opened a Technology & Innovation Center in Troisdorf and, with 48 branches, is considered a heavyweight in the industry. rahm is thus the number two among German medical supply store groups.
rahm GmbH and the Auxilium Group have signed an agreement whereby rahm will join the Auxilium Group as a strategically significant component. Meike Rahm will, like all other shareholders before her, acquire a stake in Auxilium.
The operational integration of rahm and its affiliated companies into the Auxilium Group is to take place gradually over the next two years. Marco Hammerstein will continue to serve as CEO of rahm and will also become a managing director within the Auxilium Group.
A closer connection between the parties already existed in 2023: The German Federal Cartel Office had begun reviewing the acquisition of joint control over AUX OC GmbH by Auxilium, rahm, and Friedrich Georg Streifeneder KG. The company, founded on December 21, 2022, was under the sole control of Auxilium and focused on its own-brand range of medical aids. This joint venture was thus the first step before Auxilium now seeks to fully acquire rahm.
This move would bring one of Germany’s largest medical supply companies into the group founded in 2009, which, in addition to the parent company, includes 13 other firms, such as Luttermann, Thies Medicenter, Reha Aktiv 2000, Sanitätshaus O.R.T., Meditech Sachsen, Steinke Orthopädie-Center, Sanitätshaus Carstens, and the Rehaform Group.
This would represent a merger of the two largest German medical supply groups, resulting in significant market concentration and therefore still requiring antitrust approval. The Federal Cartel Office (Decision Division B3) did not receive the case for review until the end of May 2026.
As one of the leading M&A advisory firms in the healthcare sector, ConAlliance provides comprehensive support to companies throughout all phases of acquisition and divestiture processes. Since its founding, the firm has successfully completed more than 250 transactions. The scope of its advisory services is clearly defined: ConAlliance focuses exclusively on corporate acquisitions and divestitures within the global healthcare and life sciences industries. To this end, specialized teams combine traditional investment banking expertise with deep industry knowledge in the respective healthcare niches—including the medical supply market.